|
|
||||||||
Ann Thorac Surg 2001;71:443-447
© 2001 The Society of Thoracic Surgeons
a Department of Thoracic Surgery, Hôpital Laennec, Paris, France
Accepted for publication July 17, 2000.
Address reprint requests to Dr Riquet, Département de Chirurgie Thoracique, Hôpital Laennec, 42 rue de Sèvres 75007 Paris, France
e-mail: marc.riquet{at}lnc.ap-hop-paris.fr
| Abstract |
|---|
|
|
|---|
Methods. From 1980 to 1997, 477 patients were operated on for thoracic or intrathoracic tuberculosis in Laennec Hospital, Paris (259 suffered lung diseases). There were 165 women and 94 men, aged 25 to 86 years (mean 46 years), from Europe (n = 148), North Africa (n = 65), Subsaharian Africa (n = 34), Asia (n = 7), and the West Indies (n = 5). This population was reviewed concerning the lung tuberculosis (sequelae or active lesions), the indications of lung resection, the type of resections performed, and the results at 1, 6, and 12 months.
Results. Active lesions were present in 97 cases and sequelae in 162. Surgery was performed for a therapeutic purpose in 104 patients with sequelae, and in 10 patients with active tuberculosis (pneumonectomy, n = 19; pleuropneumonectomy, n = 19; lobectomy, n = 54; and segmentectomy, n = 22). Surgery was performed for a diagnostic purpose in 54 patients with sequelae, and in 87 patients with active lesions (lobectomy, n = 32; segmentectomy, n = 19; wedge resection, n = 94, of which 11 performed by video-assisted thoracoscopy since 1991). One patient died after pleuropneumonectomy. We observed 25 complications: empyema, n = 7; hemothorax, n = 2; prolonged air leaks, n = 14; and pneumopathy, n = 2. All patients with active lesions subsequently were given antitubercular drugs. Follow-up was 100% at 1 month, 57% (n = 92) and 77% (n = 75) at 6 months for patients with sequelae and for patients with active lesions, respectively. All were asymptomatic with a normal chest roentgenogram. The number of operations for active lesions is increasing over the years, while it is decreasing for sequelar lesions.
Conclusions. In our department, surgery is being performed more frequently to make a diagnosis in cases of active tuberculosis, and to treat complicated lesions in case of sequelae. Lung resection for active tuberculosis evolving under treatment or for drug resistance was rare. However, our study confirms the good results commonly obtained by surgery and supports the idea that surgery may help eradicate tuberculosis when social and economic circumstances render its medical management difficult or hazardous.
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
Preoperative work-up included chest roentgenogram, bronchoscopy, respiratory function tests, as well as isotopic quantitative perfusion scans to predict postoperative respiratory function. Before 1985, bronchography was routinely performed and was thereafter progressively abandoned. Since 1985, chest computed tomography (CT) has been routinely performed. Since 1990, CT-guided needle biopsy has been occasionally performed for diagnosis purpose if necessary. Preoperative care in improving the nutritional status and "respiratory physiotherapy" was always undertaken in order to clear out bronchial secretions and enhance respiratory performances.
All operations were performed under general anesthesia and selective intubation of bronchi. The standard operative approach was posterolateral thoracotomy with the patient lying on the healthy side. Nineteen pneumonectomies, 19 pleuropneumonectomies, 86 lobectomies, 39 segmentectomies, and 96 wedges resections were performed. Recently, a few wedge resections were performed by video-assisted thoracoscopy, but nothing was modified in the general principles of patient setup. The patients were extubated as soon as possible at the end of the procedure and everything was performed to mobilize the patients as early as possible, including intensive respiratory physiotherapy.
Records were retrospectively reviewed for tubercular lesions and surgical indications, surgical procedures, and postoperative events. Follow-up was obtained through review of clinic consultations, written correspondence, telephone calls, or data provided by the patients private physicians. Median follow-up period was 6.9 months (range 1 to 34 months) but results were more particularly focused on the 1-, 6-, and 12-month follow-up periods.
| Results |
|---|
|
|
|---|
The types of surgical resection for group A, indications (therapeutic vs diagnostic), and the main clinical pathologies are listed in Table 1. The types of surgical resection for group B and indications (therapeutic vs diagnostic) are listed in Table 2.
|
|
Group A consisted of patients predominantly needing therapeutic operations. These patients (n = 104) were all symptomatic and presented with chronic or relapsing lung infection and had hemoptysis in one-third of cases; 95% (n = 91) had a previous history of documented and treated tuberculosis that occurred 4 to 15 years before the lung resection. Most of the operations performed were major resections, and all the pneumonectomies and pleuro-pneumonectomies (n = 38) took place in that subgroup. Diagnostic intervention in group A was for suspected malignancy. All patients were smokers and only 6 had a previous history of pulmonary tuberculosis. Among the 41 wedge resections performed, 11 have been performed by video-assisted thoracoscopy (since 1991). Morbidity was 14% and mortality was only 1% (one death). Complications after resection for group A patients are listed in Table 3. Major complications were observed after pneumonectomies and pleuropneumonectomies: seven empyemas, all cured by drainage and irrigation with antibiotics. The complications observed in other procedures were essentially prolonged air leaks, cured by chest tubes drainage. One hundred sixty-two patients in group A have been followed up at 1 month (100%), 92 at 6 months (56.8%), and 29 at 12 months (18%). All were asymptomatic and the chest roentgenogram did not show any particular anomaly.
|
| Comment |
|---|
|
|
|---|
Lung resections represented 54% of all the cases we have treated surgically over the same period (259 of 477). This is an intermediate rate when compared with other similar series that report frequencies ranging from 45% [4] to 63% [5]. However, surgery for active tuberculosis (n = 97) was indicated in only 20.3% of the whole group (97 of 477), whereas in France, 64.6% of the officially registered new cases of tuberculosis (extrathoracic included) concern the lung [1].
Lung resection for diagnostic purpose was performed in 35.8% of cases with tuberculosis sequelae and in up to 89.7% of cases that proved to be active lesions. Such an indication, 56% of the whole series, was due to the fearful idea of letting a cancer evolve. The possibility of neoplasia was outlined as a major indication as early as 1974 by McLaughlin and Hanking [6]; the frequency of such an indication may be as high as 77% [7]. Furthermore, cancer may be associated with lung tuberculosis as scar cancer in as much as 33% of cases, as reported by Rizzi and associates [8], who paradoxically excluded resections performed for tuberculoma. Most authors [4, 5, 7, 9], including us, did not report on scar cancers; however, we agree that the risk of scar cancer is an additional reason to resort to surgery for diagnostic and therapeutic purpose. Indeed, most diagnostic difficulties are encountered in case of peripheral nodular forms such as tuberculomas. Reviewing 36 cases of resected tuberculomas, Ishida and associates found 24 of them (66%) to have radiographic criteria of malignancy [10]. Percutaneous needle aspiration appears to be of limited value in these cases [4, 7], and most of the procedures were failures. Video-assisted thoracoscopy wedge resection appears to be the first-choice technique for diagnosing these nodular forms, and tubercular nodules represent 10% of video-assisted thorascopy resected coin lesions [11]. This more recent approach permits, like thoracotomy, the excision of the whole tubercular lesion and, thus, plays a major role in its treatment. It is the reason why we thought it necessary to include it in our study, contrary to Rizzi and associates [8]. Explanation of that point of view is stressed by Perelman and Strelzov [5]: "the capabilities of antibacterial therapy are limited for patients in whom tuberculosis is detected for the first time and who have tuberculomas without overt signs of exacerbation. The characteristics of the blood supply to such pathologic entities make it difficult for the drugs to act on mycobacteria efficiently. Conditions are then created for the development of secondary drug resistance by mycobacteria; there also remains the probability of exacerbation or recurrence of tuberculosis."
In our experience, surgery was rarely performed for drug-resistant tuberculosis (3 patients). Two recent French papers did not mention any patient operated on for this indication [4, 12]. Moreover, our patients did not have true multidrug-resistant disease, which is defined as having organisms resistant to at least Isoniazid and Rifampicin [13]. Yet, according to the literature, the major indication for surgical treatment of pulmonary tuberculosis is becoming true multidrug resistance [8, 1316]. This difference between countries is partly explained by a spontaneous low multiresistance rate, which is around 0.5% in France, whereas, for instance, it is 3.5% in the US [2]. However, primary resistance was observed in 6% of patients suffering lung tuberculosis in one pneumology department in Paris, 2.9% being primary resistance to Isoniazid, but no resistance to Rifampicin or Ethambutol was observed [17]. Whereas some authors have in mind the resistance of isolated tuberculous mycobacteria to several basic antituberculous drugs, others use the term to mean the absence of well-defined positive clinical and radiologic effects in response to antitubercular therapy [5]. These cases, seldom mentioned in the literature, represent 7 of 10 patients we operated on, 10 out of 12 patients operated on by Mouroux and associates [4], and as many as 129 of 347 patients operated on by Ribet [12]. The lack of efficiency of the medical treatment in such cases is not explained, but surgery proved helpful in curing them.
In our series, resection for sequelae was performed in 104 patients presenting with complicated disease, mainly infections and/or hemoptysis, sometimes life threatening. Aspergilloma was present in 36 out of these 104 patients (Table 2). Aspergilloma is not reported in some series [7, 9, 13]; sometimes its frequency is rare (one case for Mouroux and associates [4]), but it may be present in as much as 45% of patients [8].
The major operations we had to perform (pneumonectomies and pleuropneumonectomies) took place in this subgroup of patients, who presented with complicated sequelae, and we never had to perform such operations for active tuberculosis. This could be explained by the rare indications of surgery for drug-resistant tuberculosis present in our series; Pomerantz and Brown [14] performed 62 pneumonectomies in 111 patients operated on for drug-resistant tuberculosis. In a series of 20 pneumonectomies for tuberculosis [18], lung destruction was due to drug-resistant tuberculosis in 20% of the patients (4 of 20). The overall mortality and morbidity in our series was low: 0.4% (1 of 259) and 9.6% (25 of 259), respectively.
Complications occurred essentially after surgery for sequelae with therapeutic purpose, and in that subgroup, the corrected rates, 1% and 20%, respectively, are high but they remain among the low rates of the literature we have referred to. The most frequent complication we observed was prolonged postoperative air leak (n = 17) after partial lung resections. Such prolonged air leaks may be the cause of residual pleural spaces that are classically treated by secondary tailored thoracoplasty. As the risk of such spaces to occur may be great in case of upper lobe destruction, some authors even advocate pleural space obliteration through tailored thoracoplasty while performing lobectomy or pleurolobectomy when pleural space problems are anticipated [10]. We never had to perform thoracoplasty for residual pleural space and always obtained space obliteration using a chest tube inserted by posterior approach [19].
Surgery is efficient and reliable in curing tuberculosis, both sequelar and active forms. In active forms evolving under antitubercular drugs, cure is obtained in 64.8% of patients [12], and in drug-resistant active forms, cure is obtained in 80% or more [14, 16]. All patients we followed up were cured, but one has to take into consideration the high number of patients who were lost to follow-up at 6 and 12 months. Patients lost to follow-up had left their home without having given new addresses, and even their private physicians had no news concerning them. Such defection is linked to the marginal social conditions of a mainly immigrant population (86%) that make the life of the concerned patients difficult and unstable. In an other Parisian study of Brechot and associates [17], 22% of the patients were lost to follow-up 3 months after establishing the diagnosis of tuberculosis and initiating treatment; and in one medical unit of our hospital, the same rate of defection (26%) was observed [20]. Our results stress that the difficulties encountered in managing tuberculosis, which are due to the socioeconomic context surrounding a noncompliant and socially unstable population, also exist after surgery.
To conclude, in our department, surgery was more frequently performed to make a diagnosis in cases of active tuberculosis. Lung resections for tuberculosis evolving under treatment or for drug resistance were rare. However, our study confirms the good results obtained by lung resection for tuberculosis that are reported by all the authors publishing at the present time. It adds further support to the idea that surgery may be a valuable tool for eradicating residual active foci, in cases where socio-economic conditions render medical management difficult or hazardous.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. G Somocurcio, A. Sotomayor, S. Shin, S. Portilla, M. Valcarcel, D. Guerra, and J. Furin Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru Thorax, May 1, 2007; 62(5): 416 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Naidoo Active Pulmonary Tuberculosis: Experience with Resection in 106 Cases Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 134 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Olcmen, M. Z Gunluoglu, A. Demir, H. Akin, H. V Kara, and S. I Dincer Role and Outcome of Surgery for Pulmonary Tuberculosis Asian Cardiovasc Thorac Ann, October 1, 2006; 14(5): 363 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rergkliang, A. Chetpaophan, V. Chittithavorn, and P. Vasinanukorn Surgical Management of Pulmonary Cavity Associated with Fungus Ball Asian Cardiovasc Thorac Ann, September 1, 2004; 12(3): 246 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. El-Hamamsy, L-M. Stevens, L. P. Perrault, and M. Carrier Right pneumonectomy and thoracoplasty followed by coronary artery bypass grafting and mitral valve replacement J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 215 - 216. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |